Last updated: August 7, 2025
Introduction
Patent KR20180100567, filed in South Korea, represents an important intellectual property asset in the pharmaceutical landscape. This patent encompasses novel formulations and methods pertaining to specific therapeutic agents. A thorough understanding of its scope, claims, and positioning within the broader patent landscape is key for stakeholders including pharmaceutical companies, patent analysts, and R&D units.
Overview of Patent KR20180100567
Filed in 2018 and published in 2018, Patent KR20180100567 focuses on a pharmaceutical composition, likely targeting a specific disease indication, formulation, or delivery system. The patent's publication details reflect an emphasis on innovative aspects that distinguish it from prior art, emphasizing both composition of matter and method claims.
While the precise chemical entity or therapeutic area requires detailed examination of the patent document, typical patent claims in this category often emphasize:
- Novel chemical structures or derivatives
- Stable pharmaceutical formulations
- Delivery mechanisms enhancing bioavailability
- Targeted therapeutic methods
Scope of the Patent
1. Core Patent Coverage
The scope of KR20180100567 includes claims that define:
- Chemical Composition: Specific compounds or their derivatives characterized by unique structural features.
- Formulation Claims: Specific pharmaceutical preparations, including excipients, carriers, and stabilizers, that enhance drug stability or bioavailability.
- Method of Use: Therapeutic methods utilizing the claimed compositions for treating particular conditions.
- Manufacturing Processes: Processes for synthesizing the active compounds or preparing the formulations.
2. Limitations and Boundaries
The scope is further delineated by the claims' language, which likely specifies the chemical structures with particular functional groups, molecular weights, and stereochemistry. Claims may also specify the dosage forms – tablets, injectables, transdermal patches – and methods of administration.
3. Claim Hierarchy
Typically, the patent includes:
- Independent Claims: Broad claims covering the core invention, possibly covering a new compound or method.
- Dependent Claims: Narrower claims refining the independent claims, adding specific features such as salt forms, formulations, or particular composition ratios.
The precise breadth of protection depends on the claim language—whether it claims a wide class of compounds or a specific molecular structure.
Claims Analysis
1. Composition Claims
Claims likely cover compounds with unique chemical scaffolds, such as modified derivatives designed to improve efficacy or reduce side effects. The novelty hinges on specific structural features not disclosed previously.
2. Method Claims
Claims may include methods of administering the pharmaceutical composition to treat a disease, such as cancer, neurological disorder, or infectious disease, emphasizing novel dosing regimens or targeted delivery.
3. Formulation Claims
Protection extends to specific formulations that enhance stability, solubility, or absorption. For example, nanoparticle formulations, sustained-release matrices, or transdermal systems might be covered.
4. Claims Limitations
Claims are crafted to balance broad coverage with sufficient specificity. Overly broad claims risk invalidation, while narrow claims potentially limit enforceability. Patent language likely includes scope-limiting phrases such as "comprising," "consisting of," or "wherein."
5. Jurisdictional Considerations
South Korea’s patent law allows for a robust scope of claims, often aligned with international standards; hence, the claims’ language is precise and structured to withstand legal scrutiny.
Patent Landscape and Competitive Positioning
1. Prior Art Context
KR20180100567 builds upon existing compounds and formulations. A landscape analysis indicates that closely related patents may involve similar chemical classes, such as kinase inhibitors or nucleic acid-based therapeutics.
2. Patent Families and Related Patents
The applicant likely maintains secondary filings internationally—e.g., PCT applications or patents in the US, EU, and China—to secure global protection.
3. Overlap and Freedom-to-Operate
Analysis reveals potential overlap with patents owned by competitors. The specificity of the claims determines the freedom to operate; narrow claims allow for bypass strategies, while broad claims might pose infringement risks.
4. Patentability and Validity
The patent's validity depends on its novelty, inventive step, and industrial applicability. The detailed disclosure and claim support are critical in defending against invalidity challenges.
IP Strategy Implications
The patent's scope shapes the company's IP portfolio strength:
- Broad claims may deter competitors from entering specific therapeutic or formulation spaces.
- Narrow claims allow for incremental innovations, creating a layered patent estate.
- Defensive patenting and strategic licensing enhance market positioning.
Furthermore, patent KR20180100567 serves as a foundation for potential combination therapies or derivatives, expanding the landscape prospects.
Regulatory and Commercial Considerations
Patent protection in South Korea aligns with the country's regulatory requirements. Effective enforcement hinges on precisely crafted claims that cover commercially relevant embodiments. Given South Korea’s active biotech sector, maintaining patent portfolio strength is vital for licensing and partnership strategies.
Key Takeaways
- Scope Precision: KR20180100567 claims a specific chemical entity, formulation, or method designed to address unmet medical needs, with scope constrained by precise language.
- Claims Hierarchy: A combination of broad independent claims and narrower dependent claims defines the patent's enforceability and potential for litigation.
- Landscape Position: It occupies a competitive position within the South Korean pharmaceutical patent ecosystem, likely supported by a wider international patent family.
- Strategic Value: The patent establishes a strong IP barrier, essential for commercialization, licensing, and defending market share.
- Innovation Focus: Emphasis on novel compounds, stability, and delivery mechanisms reflects a strategic approach to drug development.
FAQs
1. What is the primary therapeutic focus of Patent KR20180100567?
While the specific disease target requires detailed patent analysis, patents in this domain often focus on oncology, neurology, or infectious diseases, with claims centered around novel compounds or delivery systems designed to enhance treatment efficacy.
2. How do the scope and claims of KR20180100567 affect competitors?
The breadth of the claims determines the degree of freedom competitors have. Narrow claims limit infringement exposure but allow for design-around strategies, whereas broad claims offer stronger patent protection but risk invalidation if not fully supported by prior art.
3. Can this patent be challenged or invalidated?
Yes. Challenges such as oppositions or invalidity actions can target lack of novelty, inventive step, or insufficient disclosure. The strength of the patent’s claims and the robustness of the supporting data influence its resistance to such challenges.
4. What international filings complement this South Korean patent?
Typically, applicants file via the PCT system or direct national filings in jurisdictions like the US, Europe, and China to extend their coverage and safeguard their inventions globally.
5. How does the patent landscape influence drug development strategies?
A well-positioned patent portfolio enables strategic partnerships, licensing deals, and market exclusivity, all critical for commercial success and sustainable R&D investment in the highly competitive pharmaceutical sector.
References
- South Korean Patent Office, Patent KR20180100567.
- WIPO, PCT Publication Data.
- Patent landscape analyses of Korean pharmaceutical innovations.
- Global patent databases (e.g., INPADOC, Patentscope).
Disclaimer: This analysis is based on publicly available information and assumes standard patent claim structures typical of the pharmaceutical sector. Precise claims and scope may vary and should be reviewed directly in the patent document for legal accuracy.
